We are thrilled to announce that the Cision InVision Imaging System has been recognized as one of TIME Magazine’s Best Inventions of 2023. This accolade is a remarkable achievement for Cision Vision, especially considering our relatively recent entry into the medical industry just three years ago. Our inclusion alongside established industry leaders like Abbott, Sanofi, and Thermo Fisher is a testament to our innovative approach and dedication to enhancing patient care.
This recognition by TIME Magazine, a prestigious global publication known for its authoritative insights and influential lists, underscores the significance of our invention in the medical field. TIME’s endorsement serves as a beacon of excellence, highlighting groundbreaking advancements that have the potential to reshape the grossing lab and improve patient outcomes, and it’s only just the beginning. This is our second major in addition to being awarded the Red Dot Design award in 2023 as well.
Cision InVision represents a significant leap forward for the anatomic pathology industry and the pathologists’ assistant community. It addresses a critical need in the accurate staging of solid tumors, which is crucial for developing effective treatment plans. The current standard of care for detecting lymph nodes, through which cancers can spread, relies heavily on manual examination (palpitation) of tissue sections. This traditional method, though widely used, lacks the precision and efficiency required in today’s fast-paced medical environment.
Cision InVision is a pioneering phase-contrast microscope employing cutting-edge shortwave infrared technology. Cision InVision offers a novel way to visualize lymph nodes, distinguishing them clearly from surrounding fat tissue. The enhanced visibility and accuracy provided by Cision InVision’s Enlight software, facilitates more precise cancer staging, which is vital for grossing workflow in small to large labs. This could significantly impact patient outcomes, potentially saving lives by ensuring more targeted and effective treatments. In fact, Cision InVision’s impact is already being felt across major hospital systems nationwide, including renowned institutions nationwide. Its integration into these facilities signifies a major shift towards more technologically advanced, efficient, and accurate cancer diagnosis and staging.
For the Pathologists’ Assistant community, Cision InVision is more than just a tool; it’s a catalyst for change. It empowers pathology practitioners with greater precision and confidence in their grossing capabilities, thus enhancing their role in the fight against cancer. As Dr. Jeremy Li, CEO and Co-Founder of Cision Vision, aptly puts it, “This achievement is not just a win for us, but also a significant milestone for solid tumor patients worldwide!”
We are eager to share this groundbreaking technology with more PAs in the field. To accommodate the growing interest, we are actively scheduling on-site product trials with leading institutions, from small labs to large hospitals. We also offer virtual presentations, providing an opportunity for you and your colleagues to witness the Cision InVision device in action and understand its transformative potential.
About Cision Vision
We are Cision Vision, and we help PAs, residents, and pathologists find lymph nodes more quickly and accurately by displaying lymph nodes as the opposite color as the surrounding fat in real-time without radiation or injection. Learn more about how Cision Vision can help you improve clinical workflow and patient care at your facility at cisionvision.com.
Join us in embracing this new era of anatomic pathology, where technology and innovation pave the way for improved patient care and outcomes.